Literature DB >> 21791326

Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures.

Cosme García-García1, Isaac Subirana, Joan Sala, Jordi Bruguera, Gines Sanz, Vicente Valle, Fernando Arós, Miquel Fiol, Lluis Molina, Jordi Serra, Jaume Marrugat, Roberto Elosua.   

Abstract

The aim of this study was to describe differences in the characteristics and short- and long-term prognoses of patients with first acute myocardial infarction (MI) according to the presence of ST-segment elevation or non-ST-segment elevation. From 2001 and 2003, 2,048 patients with first MI were consecutively admitted to 6 participating Spanish hospitals and categorized as having ST-segment elevation MI (STEMI), non-ST-segment elevation MI (NSTEMI), or unclassified MI (pacemaker or left bundle branch block) according to electrocardiographic results at admission. The proportions of female gender, hypercholesterolemia, hypertension, and diabetes were higher among NSTEMI patients than in the STEMI group. NSTEMI 28-day case fatality was lower (2.99% vs 5.26%, p = 0.02). On multivariate analysis, the odds ratio of 28-day case fatality was 2.23 for STEMI patients compared to NSTEMI patients (95% confidence interval 1.29 to 3.83, p = 0.004). The multivariate adjusted 7-year mortality for 28-day survivors was higher in NSTEMI than in STEMI patients (hazard ratio 1.31, 95% confidence interval 1.02 to 1.68, p = 0.035). However, patients with unclassified MI presented the highest short- and long-term mortality (11.8% and 35.4%, respectively). The excess of short-term mortality in unclassified and STEMI patients was mainly observed in those patients not treated with revascularization procedures. In conclusion, patients with first NSTEMI were older and showed a higher proportion of previous coronary risk factors than STEMI patients. NSTEMI patients had lower 28-day case fatality but a worse 7-year mortality rate than STEMI patients. Unclassified MI presented the worst short- and long-term prognosis. These results support the invasive management of patients with acute coronary syndromes to reduce short-term case fatality.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21791326     DOI: 10.1016/j.amjcard.2011.06.003

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

1.  The Quality of Symptoms in Women and Men Presenting to the Emergency Department With Suspected Acute Coronary Syndrome.

Authors:  Sahereh Mirzaei; Alana Steffen; Karen Vuckovic; Catherine Ryan; Ulf Bronas; Jessica Zegre-Hemsey; Holli A DeVon
Journal:  J Emerg Nurs       Date:  2019-02-07       Impact factor: 1.836

2.  Recent trends in post-discharge mortality among patients with an initial acute myocardial infarction.

Authors:  Andrew H Coles; Kimberly A Fisher; Chad Darling; David McManus; Oscar Maitas; Jorge Yarzebski; Joel M Gore; Darleen Lessard; Robert J Goldberg
Journal:  Am J Cardiol       Date:  2012-07-03       Impact factor: 2.778

3.  Non-STEMI vs. STEMI Cardiogenic Shock: Clinical Profile and Long-Term Outcomes.

Authors:  María José Martínez; Ferran Rueda; Carlos Labata; Teresa Oliveras; Santiago Montero; Marc Ferrer; Nabil El Ouaddi; Jordi Serra; Josep Lupón; Antoni Bayés-Genís; Cosme García-García
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

4.  The myriad essential roles of microRNAs in cardiovascular homeostasis and disease.

Authors:  Ronald L Neppl; Da-Zhi Wang
Journal:  Genes Dis       Date:  2014-03-01

5.  Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development.

Authors:  Diana Žaliaduonytė-Pekšienė; Vaiva Lesauskaitė; Rasa Liutkevičienė; Vytenis Tamakauskas; Vilius Kviesulaitis; Giedrė Šinkūnaitė-Maršalkienė; Sandrita Šimonytė; Simonita Mačiulskytė; Eglė Tamulevičiūtė-Prascienė; Olivija Gustienė; Abdonas Tamošiūnas; Remigijus Žaliūnas
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Oct-Dec       Impact factor: 1.636

6.  In-hospital prognosis and long-term mortality of STEMI in a reperfusion network. "Head to head" analisys: invasive reperfusion vs optimal medical therapy.

Authors:  C García-García; N Ribas; L L Recasens; O Meroño; I Subirana; A Fernández; A Pérez; F Miranda; H Tizón-Marcos; J Martí-Almor; J Bruguera; R Elosua
Journal:  BMC Cardiovasc Disord       Date:  2017-05-26       Impact factor: 2.298

7.  Health-related quality-of-life after percutaneous coronary intervention in patients with UA/NSTEMI and STEMI: the Korean multicenter registry.

Authors:  Mi-Jeong Kim; Doo Soo Jeon; Hyeon-Cheol Gwon; Soo-Joong Kim; Kiyuk Chang; Hyo-Soo Kim; Seung-Jea Tahk
Journal:  J Korean Med Sci       Date:  2013-06-03       Impact factor: 2.153

8.  Marital status shows a strong protective effect on long-term mortality among first acute myocardial infarction-survivors with diagnosed hyperlipidemia--findings from the MONICA/KORA myocardial infarction registry.

Authors:  Philip Andrew Quinones; Inge Kirchberger; Margit Heier; Bernhard Kuch; Ines Trentinaglia; Andreas Mielck; Annette Peters; Wolfgang von Scheidt; Christa Meisinger
Journal:  BMC Public Health       Date:  2014-01-30       Impact factor: 3.295

9.  Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study.

Authors:  Farzin Fath-Ordoubadi; Erik Spaepen; Magdi El-Omar; Douglas G Fraser; Muhammad A Khan; Ludwig Neyses; Gian B Danzi; Ariel Roguin; Dragica Paunovic; Mamas A Mamas
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

10.  Pre-event quality of life and its influence on the post-event quality of life among patients with ST elevation and non-ST elevation myocardial infarctions of a premier province of Sri Lanka.

Authors:  P K B Mahesh; M W Gunathunga; Saroj Jayasinghe; S M Arnold; R Haniffa; A P De Silva
Journal:  Health Qual Life Outcomes       Date:  2017-08-01       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.